AG
AGL icon

Algert Global’s Agilon Health AGL Stock Holding History

Algert Global’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$670K Buy
+6,250
New +$409K 0.01% 1029
2025
Q3 		– Sell
-88,224
Closed -$5.07M – 1118
2025
Q2 		$5.07M Buy
88,224
+20,425
+30% +$1.64M 0.11% 324
2025
Q1 		$7.34M Sell
67,799
-16,548
-20% -$1.44M 0.18% 161
2024
Q4 		$4.01M Buy
84,347
+76,966
+1,043% +$4.65M 0.09% 351
2024
Q3 		$725K Buy
7,381
+3,285
+80% +$424K 0.02% 823
2024
Q2 		$670K Buy
4,096
+3,274
+398% +$466K 0.02% 796
2024
Q1 		$125K Sell
822
-1,908
-70% -$317K ﹤0.01% 998
2023
Q4 		$857K Buy
2,730
+1,974
+261% +$714K 0.03% 658
2023
Q3 		$335K Sell
756
-890
-54% -$402K 0.02% 860
2023
Q2 		$713K Buy
+1,646
New +$925K 0.03% 733
2022
Q4 		– Sell
-4,400
Closed -$2.58M – 1122
2022
Q3 		$2.58M Buy
4,400
+3,475
+376% +$2.08M 0.16% 199
2022
Q2 		$505K Buy
+925
New +$468K 0.04% 756

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NPCM
North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Algert Global's AGL Position: Q2 2026 in Review

Algert Global opened a new position in Agilon Health (AGL) in Q2 2026: 6,250 shares worth $670K. The stake represents 0.01% of the portfolio and ranks #1029 among its holdings. This is a return to the name: Algert Global previously reported a position in AGL as recently as Q2 2025.

Algert Global first reported a position in AGL in Q2 2022 and has held it in 12 quarters since. The position peaked at $7.34M in Q1 2025. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Algert Global held 6,250 shares of Agilon Health worth $670K as of Q2 2026.
  • Agilon Health was a new Algert Global position in Q2 2026.
  • Agilon Health made up 0.01% of Algert Global's portfolio in Q2 2026, its #1029 holding.
  • Algert Global first reported a position in Agilon Health in Q2 2022 and has held it in 12 quarters since.
  • Algert Global's Agilon Health position peaked at $7.34M in Q1 2025.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.